Prestige Consumer Healthcare Inc. $PBH Holdings Cut by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. sold 54,861 shares of Prestige Consumer Healthcare, reducing its stake by 1.0%, and now owns approximately 5.6 million shares valued at $484.5 million.
• Prestige Consumer Healthcare reported a quarterly earnings of $0.95 per share, missing expectations, with a revenue of $249.53 million, down 6.6% from the previous year.
• Analyst consensus ratings for Prestige Consumer Healthcare indicate a "Hold" with an average target price of $93.33, following changes from several institutions regarding their ratings.

Vanguard Group Inc. trimmed its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1.0% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 5,635,298 shares of the company's stock after selling 54,861 shares during the quarter. Vanguard Group Inc. owned approximately 11.38% of Prestige Consumer Healthcare worth $484,467,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC bought a new stake in Prestige Consumer Healthcare in the 4th quarter valued at about $84,932,000. Congress Asset Management Co. increased its stake in shares of Prestige Consumer Healthcare by 9.1% in the first quarter. Congress Asset Management Co. now owns 991,580 shares of the company's stock valued at $85,246,000 after purchasing an additional 82,838 shares during the period. Westwood Holdings Group Inc. raised its holdings in shares of Prestige Consumer Healthcare by 7.1% during the first quarter. Westwood Holdings Group Inc. now owns 861,282 shares of the company's stock valued at $74,044,000 after buying an additional 56,802 shares during the last quarter. Northern Trust Corp raised its holdings in shares of Prestige Consumer Healthcare by 10.9% during the fourth quarter. Northern Trust Corp now owns 813,076 shares of the company's stock valued at $63,493,000 after buying an additional 80,055 shares during the last quarter. Finally, Bank of America Corp DE boosted its position in shares of Prestige Consumer Healthcare by 6.4% during the fourth quarter. Bank of America Corp DE now owns 594,098 shares of the company's stock worth $46,393,000 after buying an additional 35,830 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on PBH shares. Wall Street Zen lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group cut their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $93.33.

Prestige Consumer Healthcare Price Performance

NYSE:PBH traded up $0.11 during mid-day trading on Monday, reaching $65.10. 323,598 shares of the stock were exchanged, compared to its average volume of 386,622. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55. The business has a fifty day moving average price of $77.27 and a 200 day moving average price of $81.62. Prestige Consumer Healthcare Inc. has a 1-year low of $62.95 and a 1-year high of $90.04. The firm has a market capitalization of $3.20 billion, a PE ratio of 15.28, a PEG ratio of 2.05 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The business had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. During the same period in the prior year, the firm earned $0.90 EPS. The business's revenue for the quarter was down 6.6% on a year-over-year basis. Research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.